Hangzhou Realy Tech Co., Ltd

Ruili has a dedicated development facility with a large number of experienced scientists dedicated to the development of IVD reagents. Our R&D scientists are engaged in process development, process improvement, formulation and analytical development. Our product development pipeline includes chemiluminescence quantitative detection reagents, colloidal gold quantitative detection reagents, various antigens and antibodies. The facility is accredited by the State Food and Drug Administration of the Chinese government. REALY places a high priority on maintaining strict quality control at every stage of its process, as well as in product and management practices across all facilities and the organization. We check the safety of our products through extensive testing, sampling and verification procedures to align with final product specifications. Our extensive product line includes rapid detection, drug detection readers, POCT readers and automated chemiluminescent immunoassay system machines. All of these systems are compatible with nearly 150 immune marker tests in areas such as cardiovascular disease, infectious diseases, hepatitis diseases, diabetes, health checkups, and obstetrics and gynecology. It is not only suitable for the rapid diagnosis of critical diseases in large and medium-sized hospitals and laboratories, but also for the comprehensive immuno quantitative analysis of small and medium-sized hospitals and laboratories. The company has established a clean plant certified by the Food and Drug Administration and a factory of nearly 700 square meters. At present, the daily output of 1 million doses, with quantitative in vitro diagnostic kits and clinical trial machine production capacity, in addition to our own brand products, but also to provide customers with OEM services, visit the system, OTC market, the Ministry of Public Security, epidemic prevention department to provide a variety of specifications of products. Products are exported to domestic and foreign markets.